|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07C 231/10 | (2006.01) |
| C07C 233/13 | (2006.01) | ||
| A61K 31/165 | (2006.01) | ||
| C07C 231/12 | (2006.01) | ||
| C07C 231/18 | (2006.01) |
| (11) | Number of the document | 2474521 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12163085.9 |
| Date of filing the European patent application | 2007-06-08 | |
| (97) | Date of publication of the European application | 2012-07-11 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-10 |
| (46) | Date of publication of the claims translation | 2016-11-25 |
| (30) | Number | Date | Country code |
| 06012565 | 2006-06-19 | EP |
| (72) |
Barbanti, Elena, IT
Caccia, Carla, IT
Salvati, Patricia, IT
Velardi, Francesco, IT
Ruffilli, Tiziano, IT
Bogogna, Luigi, IT
|
| (73) |
Newron Pharmaceuticals S.p.A.,
Via L. Ariosto, 21, 20091 Bresso (MI),
IT
|
| (74) |
Marija LENKUTIENĖ,
Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | Aukšto grynumo laipsnio 2-[4-(3- ir 2-fluorbenziloksi)benzilamino]propanamidai, skirti naudoti kaip medikamentai, ir juos apimančios farmacinės kompozicijos |
| High purity degree 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides for use as medicaments and pharmaceutical formulations containing them |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 19 | 347.00 EUR |
| 2026-06-08 |